Research on Congenital Adrenal Hyperplasia (CAH) highlights the impact of hormonal imbalances on cardiovascular health. Glucocorticoids regulate stress and metabolism, while hyperandrogenism involves an excess of male sex hormones. These imbalances can lead to cardiovascular issues, making their management crucial for preventing such problems in CAH patients.
Understanding the relationship between hormonal imbalances and cardiovascular health can improve treatment strategies for CAH, potentially reducing long-term health risks. This insight is important for developing effective management plans for individuals with CAH, as noted by Çetin and Atar (2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
